Emory University commenced a COVID-19 vaccine clinical trial with the first agent to be evaluated, Gilead’s Remdesivir. The Emory Vaccine Treatment and Evaluation Unit (VTEU) was activated last week by the National Institute of Allergy and Infectious Diseases...